Provided by Tiger Trade Technology Pte. Ltd.

Novavax

9.23
-0.3600-3.75%
Post-market: 9.23-0.0046-0.05%19:53 EDT
Volume:3.33M
Turnover:30.83M
Market Cap:1.52B
PE:-6.08
High:9.56
Open:9.50
Low:9.16
Close:9.59
52wk High:11.97
52wk Low:6.20
Shares:164.43M
Float Shares:143.00M
Volume Ratio:0.69
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5181
EPS(LYR):2.58
ROE:-898.20%
ROA:-6.51%
PB:-7.96
PE(LYR):3.58

Loading ...

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Mabion Signs Deal with Novavax Expanding Cooperation to Analytical Services for Early-Stage Pipeline Projects

Reuters
·
Sep 14

Mabion Sa - Deal Covers Implementation and Provision of Analytical Services for Novavax's Early-Stage Pipeline Projects

THOMSON REUTERS
·
Sep 14

Mabion Sa - Signs Statement of Work #12 with Novavax to Expand Cooperation Under Existing Manufacturing Agreement

THOMSON REUTERS
·
Sep 14

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 12

Novavax Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 10

Novavax Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Novavax to Present at Cantor Global Healthcare Conference in Fireside Chat

Reuters
·
Sep 03

Unusually active option classes on open September 2nd

TIPRANKS
·
Sep 02

Novavax call volume above normal and directionally bullish

TIPRANKS
·
Sep 01

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Novavax Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

Novavax’s partners approved for Nuvaxovid formulation for vaccination season

TIPRANKS
·
Aug 28

Novavax's Partnership Strategy Continues to Deliver with Xfg-Adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season

THOMSON REUTERS
·
Aug 28

Novavax, - Eligible for Royalties on Net Sales in U.S., EU, Japan for 2026-2027 Season

THOMSON REUTERS
·
Aug 28

Sanofi Spokesperson Says Nuvaxovid to be Available Across U.S. for 2026-27 Respiratory Virus Season

Reuters
·
Aug 28

Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

Novavax Inc. Stock Rallies 6.5%, Outperforms Peers

Dow Jones
·
Aug 26